Dare Bioscience, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
DARE chart
What traders are saying about $DARE
Latest postsDare Bioscience, Inc. news
- Daré Bioscience, Inc. (DARE) stock price, news, quote and history
Yahoo Finance UK ·
- Daré Bioscience, Inc. (DARE) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- DARE Assumes Buy Rating by Ladenburg Thalmann -- Price Target An
GuruFocus ·
- Daré Bioscience to Showcase Its Investigational Programmable Device, DARE-IDDS, at PODD 2026: One Device, Designed to Deliver 100+ Doses and to be Controlled Wirelessly
Yahoo Finance ·
- One implant is designed to replace months to years of repeat injections
Stock Titan ·
- Dare Bioscience, Inc. Estimates – NASDAQ:DARE
TradingView ·
- Daré Bioscience Sponsors HERmedicine Educational Program for Clinicians on Managing Menopause After Breast Cancer
Yahoo Finance ·
- Daré Bioscience Launches “CEO Corner” Video Series to Highlight the Company’s Pipeline of Women’s Health Innovations, Corporate Strategy and Opportunities
Yahoo Finance ·
- Daré Bioscience to Present Phase 1 Sildenafil Cream Data at Sexual Medicine Society of North America (SMSNA) Annual Fall Scientific Meeting
Yahoo Finance ·
- Dare Bioscience stock rises after receiving HPV treatment patent
Yahoo Finance ·
- Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program as a Potential First FDA-Approved Pharmacologic Treatment for HPV Infection
Yahoo Finance ·
- Daré Bioscience Announces Peer-Reviewed Publication of Phase 1 Sildenafil Cream Study in Men Demonstrating Substantially Lower Systemic Exposure Versus Oral Sildenafil
Yahoo Finance ·
Dare Bioscience, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $1.0M | $9,784 | $2.8M | $10.0M |
| Net income | -$13.4M | -$4.0M | -$30.2M | -$30.9M |
| Diluted EPS | $-1.20 | $-0.48 | $-4.15 | $-0.37 |
| Total assets (year end) | $32.5M | $22.1M | $21.3M | $43.8M |
| Cash and equivalents (year end) | $24.7M | $15.7M | $10.5M | $34.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Dare Bioscience, Inc.
- Ticker
- DARE (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1401914
- Former names
- Cerulean Pharma Inc., Tempo Pharmaceuticals Inc
Frequently asked questions
What exchange is Dare Bioscience, Inc. listed on?
Dare Bioscience, Inc. trades on the Nasdaq under the ticker symbol DARE.
What industry is Dare Bioscience, Inc. in?
Dare Bioscience, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Dare Bioscience, Inc. headquartered?
Dare Bioscience, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Dare Bioscience, Inc.'s fiscal year end?
Dare Bioscience, Inc.'s fiscal year ends on December 31.
How much revenue did Dare Bioscience, Inc. report?
Dare Bioscience, Inc. reported $1.0M in revenue for calendar year 2025, according to its SEC filings.